Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection

Microbiome

Volumn 4, Issue , 2016, Pages

  Cribbs, Sushma K ^a,b   Uppal, Karan ^b   Li, Shuzhao ^b   Jones, Dean P ^b   Huang, Laurence ^c   Tipton, Laura ^d,e   Fitch, Adam ^d   Greenblatt, Ruth M ^c   Kingsley, Lawrence ^f   Guidot, David M ^a,b   Ghedin, Elodie ^e   Morris, Alison ^d  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bronchoalveolar lavage; HIV; Lung; Metabolomics; Microbiota

Indexed keywords

CARBOHYDRATE; CYSTINE; RNA 16S; TYROSINE DERIVATIVE; 3,5-DIBROMOTYROSINE; GLYCEROPHOSPHOLIPID; TYROSINE;

ACUTE RESPIRATORY TRACT DISEASE; ANALYTICAL PARAMETERS; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CAULOBACTERACEAE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID CHROMATOGRAPHY; LUNG MICROBIOTA; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MASS TO CHARGE RATIO; METABOLISM; METABOLOMICS; MICROFLORA; NOCARDIOIDACEAE; PRIORITY JOURNAL; STAPHYLOCOCCACEAE; STREPTOCOCCUS; ADULT; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; CLASSIFICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; LEAST SQUARE ANALYSIS; LUNG; METABOLOME; MICROBIOLOGY; NOCARDIACEAE; SEQUENCE ANALYSIS; VIROLOGY;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CAULOBACTERACEAE; CHROMATOGRAPHY, LIQUID; CYSTINE; FEMALE; GLYCEROPHOSPHOLIPIDS; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; LEAST-SQUARES ANALYSIS; LUNG; MALE; MASS SPECTROMETRY; METABOLOME; MICROBIOTA; NOCARDIACEAE; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA; STAPHYLOCOCCACEAE; STREPTOCOCCUS; TYROSINE;

EID: 84997194361     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/s40168-016-0147-4     Document Type: Article

References (37)

1. Huse SM, Ye Y, Zhou Y, Fodor AA. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS ONE. 2012;7:e34242. doi:10.1371/journal.pone.0034242.
2. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013;187:1067-75. doi:10.1164/rccm.201210-1913OC.
3. Johnson JM, Strobel FH, Reed M, Pohl J, Jones DP. A rapid LC-FTMS method for the analysis of cysteine, cystine and cysteine/cystine steadystate redox potential in human plasma. Clin Chim Acta. 2008;396:43-8. doi:10.1016/j.cca.2008.06.020.
4. Ghannoum MA, Mukherjee PK, Jurevic RJ, Retuerto M, Brown RE, Sikaroodi M, et al. Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets. OMICS. 2011. doi: 10.1089/omi.2011.0035
5. Wikoff WR, Pendyala G, Siuzdak G, Fox HS. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J Clin Invest. 2008;118:2661-9. doi:10.1172/JCI34138.
6. Cribbs SK, Park Y, Guidot DM, Martin GS, Brown LA, Lennox J, et al. Metabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls. AIDS Res Hum Retroviruses. 2014;30:579-85. doi:10.1089/AID.2013.0198.
7. Kozlowska J, Rivett DW, Vermeer LS, Carroll MP, Bruce KD, Mason AJ, Rogers GB (2013) A relationship between growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation. Metabolomics 9. doi: 10.1007/s11306-013-0538-5.
8. Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006;8:1865-79.
9. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol. 2008;295:C849-68. doi:10.1152/ajpcell.00283.2008.
10. Berg JM, Tymoczko JL, Stryer L. Fatty acids are synthesized and degraded by different pathways. In: Biochemistry 5th Edition. New York: W H Freeman; 2002. Available from: http://www.ncbi.nlm.nih.gov/books/NBK22554.
11. Coaccioli S, Crapa G, Fantera M, Del Giorno R, Lavagna A, Standoli ML, et al. Oxidant/antioxidant status in patients with chronic HIV infection. Clin Ter. 2010;161:55-8.
12. Cribbs SK, Guidot DM, Martin GS, Lennox J, Brown LA. Anti-retroviral therapy is associated with decreased alveolar glutathione levels even in healthy HIVinfected individuals. PLoS ONE. 2014;9:e88630. doi:10.1371/journal.pone. 0088630.
13. Lassiter C, Fan X, Joshi PC, Jacob BA, Sutliff RL, Jones DP, et al. HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction. AIDS Res Ther. 2009;6:1.
14. Droge W, Eck HP, Gmunder H, Mihm S. Dysregulation of plasma amino acid levels in HIV-infection and cancer and its relevance for the immune system. Amino Acids. 1991;1:193-8. doi:10.1007/BF00806916.
15. Droge W, Eck HP, Gmunder H, Mihm S. Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivatives. Am J Med. 1991;91:140S-4.
16. Droge W, Eck HP, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction�a rationale for treatment with N-acetylcysteine. Immunol Today. 1992;13:211-4. doi:10.1016/0167-5699(92)90156-2.
17. Kinscherf R, Fischbach T, Mihm S, Roth S, Hohenhaus-Sievert E, Weiss C, et al. Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells. FASEB J. 1994;8:448-51.
18. Amara A, Chaugier C, Ragnaud JM, Geffard M. Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients. Clin Exp Immunol. 1994;96:379-83.
19. Katamura K, Shintaku N, Yamauchi Y, Fukui T, Ohshima Y, Mayumi M, et al. Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J Immunol. 1995;155:4604-12.
20. Khoo SH, Wilkins EG, Fraser IS, Hamour AA, Stanford JL. Lack of skin test reactivity to common mycobacterial antigens in human immunodeficiency virus infected individuals with high CD4 counts. Thorax. 1996;51:932-5.
21. Hoffman AG, Lawrence MG, Ognibene FP, Suffredini AF, Lipschik GY, Kovacs JA, et al. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia. Chest. 1992;102:1730-6.
22. Liao W, Tan G, Zhu Z, Chen Q, Lou Z, Dong X, et al. Combined metabonomic and quantitative real-time PCR analyses reveal systems metabolic changes in Jurkat T-cells treated with HIV-1 Tat protein. J Proteome Res. 2012;11:5109-23. doi:10.1021/pr300173c.
23. Cilloniz C, Torres A, Polverino E, Gabarrus A, Amaro R, Moreno E, et al. Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome. Eur Respir J. 2014;43:1698-708. doi:10.1183/09031936.00155813.
24. Torres-Tortosa M, Arrizabalaga J, Villanueva JL, Galvez J, Leyes M, Valencia ME, et al. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases. Chest. 2003;123:1970-6.
25. Volpe GE, Ward H, Mwamburi M, Dinh D, Bhalchandra S, Wanke C, et al. Associations of cocaine use and HIV infection with the intestinal microbiota, microbial translocation, and inflammation. J Stud Alcohol Drugs. 2014;75:347-57.
26. Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Beck JM, Huffnagle GB, et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc. 2015;12:821-30. doi:10.1513/AnnalsATS.201501-029OC.
27. Cui L, Lucht L, Tipton L, Rogers MB, Fitch A, Kessinger C et al. Topographical diversity of the respiratory tract mycobiome and alteration in HIV and lung disease. Am J Respir Crit Care Med. 2015. doi:10.1164/rccm.201409-1583OC
28. Fitzpatrick ME, Gingo MR, Kessinger C, Lucht L, Kleerup E, Greenblatt RM, et al. HIV infection is associated with diffusing capacity impairment in women. J Acquir Immune Defic Syndr. 2013;64:284-8. doi:10.1097/QAI. 0b013e3182a9213a.
29. Crothers K, McGinnis K, Kleerup E, Wongtrakool C, Hoo GS, Kim J, et al. HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr. 2013;64:271-8. doi:10.1097/QAI.0b013e3182a9215a.
30. Lozupone C, Cota-Gomez A, Palmer BE, Linderman DJ, Charlson ES, Sodergren E, et al. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med. 2013;187:1110-7. doi:10.1164/rccm.201211-2145OC.
31. Iwai S, Fei M, Huang D, Fong S, Subramanian A, Grieco K, et al. Oral and airway microbiota in HIV-infected pneumonia patients. J Clin Microbiol. 2012;50:2995-3002. doi:10.1128/JCM.00278-12.
32. Schloss PD, Gevers D, Westcott SL. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE. 2011;6:e27310. doi:10.1371/journal.pone.0027310.
33. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71:8228-35. doi:10.1128/AEM.71.12.8228-8235.2005.
34. Uppal K, Soltow QA, Strobel FH, Pittard WS, Gernert KM, Yu T, et al. xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinformatics. 2013;14:15. doi:10.1186/1471-2105-14-15.
35. Smyth G. Limma: linear models for microarray data. In: Gentleman VCR, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. 2005. p. 397-420.
36. Soltow Q, Strobel F, Mansfield K, Wachtman L, Park Y, Jones DP. Highperformance metabolic profiling with dual chromatography-Fouriertransform mass spectrometry (DC-FTMS) for study of the exposome. Metabolomics. 2011. In press.
37. Le Cao KA, Rossouw D, Robert-Granie C, Besse P. A sparse PLS for variable selection when integrating omics data. Stat Appl Genet Mol Biol. 2008;7: Article. doi:10.2202/1544-6115.1390.